What is Sarepta Therapeutics, Inc.'s net change in cash?

Sarepta Therapeutics, Inc. (SRPT) reported net change in cash of -$336.83M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s net change in cash changed year-over-year?

Sarepta Therapeutics, Inc.'s net change in cash increased by 60.9% year-over-year, from -$862.14M to -$336.83M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Sarepta Therapeutics, Inc. SRPT Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Regeneron PharmaceuticalsREGN

-$153.1M-125%

BioMarin PharmaceuticalsBMRN

$1.76B+1,562%

PTC TherapeuticsPTCT

-$147.9M-121%

InsmedINSM

$71.74M+147%

Capricor TherapeuticsCAPR

-$182.43M-1,142%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s net change in cash?: Sarepta Therapeutics, Inc. (SRPT) reported net change in cash of -$336.83M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s net change in cash changed year-over-year?: Sarepta Therapeutics, Inc.'s net change in cash increased by 60.9% year-over-year, from -$862.14M to -$336.83M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.